PO.PR01.03 · 预防研究

妊娠、哺乳及退化诱导健康女性乳腺组织的重塑和细胞状态变化

Pregnancy, lactation, and involution-induced remodeling and cell state changes in breast tissues of healthy women

海报缩略图:妊娠、哺乳及退化诱导健康女性乳腺组织的重塑和细胞状态变化
编号 6326 展板 12 时间 4/21 02:00–05:00 区域 Section 36 主讲 Harikrishna Nakshatri, PhD
分会场 Genomics, Proteomics, Biomarkers, and Risk Stratification
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Poornima Bhat-Nakshatri1, Cihat Erdogan1, Hongyu Gao1, Yunlong Liu1, Rana German1, Michele L. Cote2, Harikrishna Nakshatri1

1Indiana University School of Medicine, Indianapolis, IN,2IUPUI Fairbanks School of Public Health, Indianapolis, IN

摘要 Abstract

中文摘要
妊娠、哺乳和退化对乳腺癌发病率和肿瘤侵袭性具有相反的作用。哺乳及随后的退化可预防乳腺癌,而妊娠相关性乳腺癌(在妊娠期间及产后2年内诊断的乳腺癌)则与不良预后相关。要清晰理解生殖周期这些相反的作用,需要对妊娠、哺乳和退化期间的乳腺进行单细胞分辨率解析。我们近期报道了一个来自不同遗传血统女性乳腺组织的参考单核染色质可及性和转录组图谱,并报道了乳腺中的10种主要细胞类型。这些细胞类型包括三种上皮细胞类型[管腔激素感应细胞(LHS)、管腔适应性分泌前体细胞(LASP)和基底-肌上皮细胞(BM)]、两种脂肪细胞亚型、两种内皮细胞亚型、T细胞、巨噬细胞和成纤维细胞。在本研究中,我们生成了在妊娠、哺乳和退化期间采集的健康女性乳腺组织的单核图谱。妊娠、哺乳和退化与细胞类型比例的显著变化以及细胞类型内部的细胞状态转变相关。LASP细胞数量从正常参考乳腺中的24%增加至妊娠期间的71%、哺乳期间的63%,但在退化期间回落至25%。妊娠、哺乳和退化期间LASP细胞状态也发生了显著转变。正常参考乳腺和妊娠期乳腺中的LASP细胞既处于LASP-基底-管腔(LASP-BL)状态又处于LASP-腺泡(LASP-AP)状态,而LASP-AP细胞在哺乳期和退化期乳腺中占主导地位。妊娠和哺乳期间LASP细胞的增加以BM细胞为代价,后者从正常参考乳腺中的27%减少至妊娠和哺乳期间的7-9%。虽然T细胞比例在正常参考乳腺和妊娠期乳腺之间相似(2-3%),但在哺乳和退化期间增至7-8%,近期一项研究提示这与哺乳相关的乳腺癌保护作用有关。哺乳和退化期间T细胞的增加可能是由于组织驻留T(TRM)细胞的扩增,因为哺乳期和退化期乳腺的T细胞表达了更高水平的TRM细胞标志物CD69和CXCR6。我们在单个基因和细胞类型水平上呈现了与妊娠、哺乳和退化相关的染色质可及性和转录组变化。已鉴定出若干与这些变化相关的生物标志物,这将成为从机制上评估乳腺随生殖史演变及乳腺癌发生的有用资源。
查看英文原文 English abstract
Pregnancy, lactation, and involution have opposing effects on breast cancer incidence and tumor aggressiveness. While breast feeding and subsequent involution protects against breast cancers, pregnancy-associated breast cancers (breast cancers diagnosed during pregnancy and within 2 years postpartum) are associated with poor outcome. Clear understanding of these opposing effects of reproductive cycle needs single cell resolution of breasts during pregnancy, lactation and involution. We recently reported a reference single nucleus chromatin accessibility and transcriptome atlas of breast tissues of women of diverse genetic ancestry and reported 10 major cell types in the breasts. These include three epithelial cell types [luminal hormone sensing (LHS), luminal adaptive secretory precursors (LASP), and basal-myoepithelial cells (BM)], two adipocyte subtypes, two endothelial cell subtypes, T cells, macrophages, and fibroblasts. In this study, we generated single nucleus atlas of breast tissues of healthy women collected during pregnancy, lactation, and involution. Pregnancy, lactation, and involution are associated with dramatic changes in cell type proportions and cell state shifts within a cell type. LASP cell numbers increased from 24% in the normal reference breasts to 71% during pregnancy, 63% during lactation but returned to 25% during involution. There is also a dramatic shift in LASP cell states during pregnancy, lactation and involution. While the LASP cells in the normal reference breasts and breasts during pregnancy were in both LASP-basal-luminal (LASP-BL) and LASP-alveolar (LASP-AP) states, LASP-AP cells were dominant in lactating and involuting breasts. Increase in LASP cells during pregnancy and lactation is at the expense of BM cells, which reduced from 27% in the normal reference breasts to 7-9% during pregnancy and lactation. While T cell proportion was similar between normal reference and pregnant breasts (2-3%), it increased to 7-8% during lactation and involution, which a recent study has suggested to be responsible for breast feeding-associated protection against breast cancer. Increase in T cells during lactation and involution is likely due to expansion of tissue resident T (T RM ) cells as T cells of lactating and involuting breasts expressed higher levels of T RM cell markers CD69 and CXCR6. We present pregnancy, lactation and involution-associated chromatin accessibility and transcriptome changes at individual gene and cell type levels. Several biomarkers associated with these changes have been identified, which will be a useful resource to mechanistically evaluate evolution of breasts during reproductive history and breast cancer development.
利益披露 Disclosure
P. Bhat-Nakshatri, None.. C. Erdogan, None.. H. Gao, None.. R. German, None.. M. L. Cote, None.. H. Nakshatri, None.

← 返回 AACR 2026 检索